SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : QLT PhotoTherapeutics (QLTI) -- Ignore unavailable to you. Want to Upgrade?


To: JAMES BORECKI who wrote (280)3/8/1998 6:16:00 PM
From: Barron Von Hymen  Read Replies (2) | Respond to of 1321
 
Don't panic. Your quote is taken out of context. The article just illustrates the benefits of using 730 nM light over 630 nM light. The 630 nM light caused substantial collateral damage and more heat damage to normal tissue. 730 nM light supposedly doesn't affect tissue that is not bound by Photofrin and penetrates better than 630 nM light.